Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Published online before print December 5, 2001, 10.1148/radiol.2221010640

(Radiology 2002;222:70.)

A more recent version of this article appeared on January 1, 2002
This Article
Right arrow Full Text
Right arrow All Versions of this Article:
2221010640v1
222/1/70    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vance, P. L.
Right arrow Articles by Schirmer, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Vance, P. L.
Right arrow Articles by Schirmer, B.
© RSNA, 2001

Vascular and Interventional Radiology

Gastric Outlet Obstruction Following Surgery for Morbid Obesity: Efficacy of Fluoroscopically Guided Balloon Dilation1

Peter L. Vance, MD2, Eduard E. de Lange, MD, Hubert A. Shaffer, Jr, MD and Bruce Schirmer, MD

1 From the Departments of Radiology (P.L.V., E.E.d.L., H.A.S.) and Surgery (B.S.), University of Virginia Health System, Lee St, HSC 800170, Charlottesville, VA 22908. From the 1999 RSNA scientific assembly. Received March 19, 2001; revision requested April 23; revision received June 25; accepted July 5. Address correspondence to E.E.d.L. (e-mail: delange @virginia.edu).

PURPOSE: To evaluate the efficacy of fluoroscopically guided balloon dilation (FGBD) in patients with symptoms of gastric outlet obstruction following surgery for morbid obesity.

MATERIALS AND METHODS: Forty-one FGBDs were performed in 28 patients with symptoms of gastric outlet obstruction following gastric restrictive surgery for morbid obesity. The efficacy of FGBD was determined using five end points: (a) no recurring symptoms for an interval of at least 3 months, or recurring symptoms treated either (b) surgically, (c) with endoscopically guided balloon dilation (EGBD), (d) with FGBD, or (e) medically.

RESULTS: Following initial FGBD, 11 of 28 patients (39%) remained asymptomatic during at least 3 months of follow-up. Recurrent dysphagia occurred in 17 patients (60%), who were treated either surgically (n = 3), with EGBD (n = 4), with FGBD (n = 9), or medically (n = 1). Of the nine patients who underwent a second FGBD, two became asymptomatic. The seven patients who remained symptomatic were treated with surgery (n = 3), EGBD (n = 1), or FGBD (n = 3). Of the three patients treated with a third FGBD, one became asymptomatic. Overall, FGBD was effective in 14 (50%) of 28 patients.

CONCLUSION: Among patients with symptoms of obstruction following gastric surgery for morbid obesity, 50% experienced relief of symptoms following FGBD.

Index terms: Gastrointestinal tract, interventional procedures, 729.12168 • Interventional procedures, utilization • Obesity, 48.837 • Stomach, interventional procedures, 729.12168, 729.126 • Stomach, stenosis or obstruction, 729.458




This article has been cited by other articles:


Home page
RadiologyHome page
E. M. Merkle, P. T. Hallowell, C. Crouse, D. A. Nakamoto, and T. A. Stellato
Roux-en-Y Gastric Bypass for Clinically Severe Obesity: Normal Appearance and Spectrum of Complications at Imaging
Radiology, March 1, 2005; 234(3): 674 - 683.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE
Copyright © 2001 by the Radiological Society of North America.